Transdermal Testosterone
Active Substance: Transdermal Testosterone
Description
Transdermal Testosterone is a form of Testosterone Replacement Therapy (TRT) where the hormone is absorbed through the skin, bypassing the digestive system and liver metabolism.
Detailed Explanation and Different Names
This delivery method allows for a relatively steady level of testosterone in the bloodstream, often mimicking the body's natural circadian rhythm if applied daily in the morning.
Different Names (Common Brand Names):
-
Gels:
-
AndroGel (Testosterone gel 1% and 1.62%)
-
Testim (Testosterone gel 1%)
-
Vogelxo (Testosterone gel)
-
Fortesta (Testosterone gel, applied to the thighs)
-
-
Solutions/Roll-ons:
-
Axiron (Testosterone topical solution, applied to the armpit)
-
-
Patches:
-
Androderm (Testosterone transdermal patch)
-
Side Effects and Benefits
Transdermal testosterone, like all forms of TRT, is primarily used to treat hypogonadism (low testosterone levels) in adult men.
Pros and Cons
Dosage and Frequency
The optimal dose is highly individualized and is adjusted based on a patient's symptoms and blood test results to achieve testosterone levels in the normal range (e.g., 300 to 1000 ng/dL).
-
Frequency: Once daily, usually in the morning.
-
Typical Starting Dosages:
-
Gels/Solutions (e.g., AndroGel 1.62%): Often starting at 40.5 mg of testosterone daily (e.g., 2 pump actuations or 1 packet).
-
Patches (e.g., Androderm): Typically a 4 mg/day patch applied nightly.
-
Half-Life and Detection Time
-
Serum T Levels: Following discontinuation, serum testosterone levels typically return to pretreatment levels within 5 days for transdermal gels/solutions.
-
Drug Testing (Detection): For performance-enhancing drug testing, detection is based on the ratio of testosterone to its metabolites (like epitestosterone) in urine. Because testosterone is an endogenous (naturally produced) substance, it is hard to give an exact detection window. Detection of exogenous (external) testosterone can last for weeks to months, depending on the sensitivity of the test and the specific formulation used, as metabolites can linger.
Sterogenic, Progestronic, Prolactin, and Anabolic/Androgenic Ratio
Sterogenic and Progestronic Effects
Testosterone itself is primarily an androgenic and anabolic steroid.
-
Sterogenic (Estrogenic) Effects: Testosterone is converted into the potent estrogen Estradiol (E2) by the aromatase enzyme. This conversion is responsible for some beneficial effects (like bone health) but also for side effects like gynecomastia and fluid retention. Transdermal administration, compared to high-dose injections, generally leads to more stable E2 levels.
-
Progestronic Effects: Testosterone and its derivatives typically have negligible or no direct progestogenic activity.
Prolactin Affects
-
Testosterone replacement therapy generally does not significantly change prolactin levels in men. While very high doses of certain anabolic-androgenic steroids can potentially influence prolactin, therapeutic transdermal TRT is not typically associated with hyperprolactinemia (elevated prolactin).
Anabolic Androgenic Ratio
The ratio of a steroid's anabolic (muscle-building) effects to its androgenic (masculinizing/secondary sex characteristics) effects is used to characterize its activity.
-
Testosterone is considered the baseline and has an Anabolic:Androgenic Ratio of 100:100 (or simply 1:1).
Pharmacological Properties
Half Life
7.2 hours
Active Dose
100%
Detection
1.50 days
Concentration
50 mg/ml
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
High
Progestanic
None
Water Retention
High
Aromatization
Yes
Benefits
Dosage Recommendations
Beginner
200-400 mg/week
Intermediate
400-600 mg/week
Advanced
600-800 mg/week
Evidence-based planning resources
Dive deeper into Transdermal Testosterone cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Transdermal Testosterone compound database overviewCompare Transdermal Testosterone with other steroid agents in the structured compound index.
- Transdermal Testosterone stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Transdermal Testosterone.
- Harm-reduction guide for Transdermal TestosteroneRefresh safety monitoring, lab work, and countermeasure strategies tailored for Transdermal Testosterone protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Transdermal Testosterone with trusted clinical databases.
- Transdermal Testosterone clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Transdermal Testosterone pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Common
Severe
Safety Information
Liver Toxicity
None
Kidney Toxicity
Low
Cardiovascular Risk
Moderate
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.